Clinical Trials
27
Active:0
Completed:18
Trial Phases
4 Phases
Phase 1:1
Phase 2:5
Phase 3:7
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (27 trials with phase data)• Click on a phase to view related trials
Not Applicable
14 (51.9%)Phase 3
7 (25.9%)Phase 2
5 (18.5%)Phase 1
1 (3.7%)Phase III Trial of Stage I Ovarian Cancer After Surgery
Phase 3
Recruiting
- Conditions
- Epithelial Ovarian Cancer
- Interventions
- Drug: adjuvant chemotherapy
- First Posted Date
- 2019-08-21
- Last Posted Date
- 2019-08-30
- Lead Sponsor
- Japanese Gynecologic Oncology Group
- Target Recruit Count
- 360
- Registration Number
- NCT04063527
- Locations
- 🇯🇵
Aichi Medical University Hospital, Nagakute-shi, Aichi, Japan
🇯🇵Tosei General Hospital, Seto-shi, Aichi, Japan
🇯🇵Fujita Health University Hospital, Toyoake-shi, Aichi, Japan
Trial of Tri-weekly TJ Versus Weekly TJ for Stage II-IV Mullerian Carcinoma
Phase 3
Completed
- Conditions
- Primary Peritoneal CancerEpithelial Ovarian CancerFallopian Tube Cancer
- Interventions
- Drug: Paclitaxel+Carboplatin
- First Posted Date
- 2005-09-27
- Last Posted Date
- 2020-02-17
- Lead Sponsor
- Japanese Gynecologic Oncology Group
- Target Recruit Count
- 637
- Registration Number
- NCT00226915
- Locations
- 🇯🇵
National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
News
No news found